Ac immune provides update on alzheimer's prevention initiative study evaluating crenezumab in autosomal dominant alzheimer's disease

Crenezumab did not statistically significantly slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset alzheimer's disease

ACIU Ratings Summary

ACIU Quant Ranking